The Festival Today
A great deal has changed since the first Festival in 2015.
I am particularly proud that we continue to provide free access to so many attendees, maintain a strong focus on translational science and patient impact, and create a place where people from across life sciences can meet, learn and work across traditional boundaries.
What has also become increasingly clear is that genomics cannot always be beneficial in isolation.
Understanding biology and improving patient outcomes increasingly means combining genomic information with other forms of biodata, transcriptomics, proteomics and multi-omics; developing new diagnostic approaches such as liquid biopsy; applying techniques including single-cell and spatial analysis; and using AI to transform research, drug discovery, development and healthcare.
That's why the Festival has expanded.
It is no longer simply a genomics meeting, even though we have more to offer the core genomics community than ever. It has become a gathering for the wider life sciences community - built around the belief that the biggest advances happen when different disciplines, technologies and people come together.
The science has broadened. The Festival has grown. But the ambition remains similar to where we started: bring the right people together, accelerate meaningful progress, and ultimately help improve outcomes for patients.